STOCK TITAN

IFF Launches VERDIGEL™ SC for Carrageenan-free, Vegan Softgel Innovation

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary

On April 19, 2023, IFF announced the launch of its innovative pectin-based technology, VERDIGEL™ SC, enhancing its vegan softgel offerings. This technology aims to cater to rising consumer demand for carrageenan-free supplements, providing manufacturers with a versatile solution without compromising quality or stability. VERDIGEL™ SC only requires the addition of water and a plasticizer, ensuring ease of production. The product aligns with consumer preferences as it is vegan, halal, kosher, and non-GMO, containing no gluten, allergens, or preservatives. IFF will showcase this new technology at Vitafoods Europe in Geneva from May 9-11, highlighting its commitment to meeting evolving customer needs in the nutraceutical sector.

Positive
  • Launch of VERDIGEL™ SC enhances vegan softgel offerings.
  • Product addresses growing consumer demand for carrageenan-free alternatives.
  • Easy implementation requiring only water and a plasticizer.
  • VERDIGEL™ SC is vegan, halal, kosher, non-GMO, and free of gluten and allergens.
Negative
  • None.

NEW YORK, April 19, 2023 /PRNewswire/ -- IFF, a leading manufacturer of functional ingredients, excipients and flavors for dietary supplements, pharmaceutical products, and biotechnology, today announced the launch of its new pectin-based technology, a further expansion of its vegan softgel offering. The introduction of VERDIGEL™ SC enables manufacturers of vegan softgels to offer carrageenan-free products, which are in high demand in several markets.

Across the world, an increasing consumer preference for vegan supplements is driving producers to meet this growing demand. Softgels are gaining popularity and becoming a format of choice in the nutraceutical and supplement sectors, but they present several manufacturing challenges, including strength and stability–particularly with increasingly complex and sensitive active ingredients.

"VERDIGEL™ SC was developed to provide manufacturers looking to switch to plant-based, carrageenan-free alternatives without disrupting their production processes and compromising the performance and quality that they need from this popular dosage form," said Rebecca Putans, R&D scientist, IFF. "Ultimately, this is about providing choice and flexibility for our customers, so they can unlock softgel possibilities, accelerate their time to market and respond swiftly to changes in consumer preferences." 

VERDIGEL™ SC is a ready-to-use pectin-based premix, requiring only the addition of water and a plasticizer to produce high-performance softgels. It is designed for easy implementation and efficient use, suitable for a wide range of formulations, and maintains the same processability and stability as other vegan and animal-based softgel approaches. VERDIGEL™ SC offers significant processing benefits as well as labeling advantages as it is vegan, halal, kosher, non-GMO, and contains no gluten, allergens or preservatives.

"Today's announcement is a proud moment as we again expand our vegan softgel technology platform, to provide our customers with even more differentiated options to create high-quality plant-based soft capsules with excellent consumer acceptance and appeal," added Benjamin Roscoe, application development and innovation manager, IFF. "At IFF, we are committed to providing innovative solutions that meet the evolving needs of our customers and the industry. With a long, proud history in the pharmaceutical and nutraceutical industries, and a decade of experience in softgel development, we are uniquely positioned to partner with formulators and producers to develop the novel delivery forms of tomorrow."

VERDIGEL™ SC will be available at IFF booth C80 during Vitafoods Europe in Geneva, Switzerland from May 9-11. Visitors will have the opportunity to find out more about the carrageenan-free vegan softgel samples and meet with IFF experts on-site. Meetings with a VERDIGEL™ SC representative at Vitafoods can be arranged here.

To learn more about VERDIGEL™ SC, its applications and benefits, visit here.

Welcome to IFF

At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.comTwitter , FacebookInstagram, and LinkedIn.

©2023 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contact:
Reena Chaudhary
Senior Specialist Global Communications
+91 9769820494
reena.chaudhary@iff.com

SOURCE IFF

FAQ

What is the new product launched by IFF on April 19, 2023?

IFF launched VERDIGEL™ SC, a pectin-based technology aimed at enhancing vegan softgel offerings.

What are the benefits of VERDIGEL™ SC?

VERDIGEL™ SC provides an easy-to-use solution for manufacturers, requiring only water and a plasticizer, and is free from gluten, allergens, and preservatives.

Where will IFF showcase the VERDIGEL™ SC product?

IFF will showcase VERDIGEL™ SC at Vitafoods Europe in Geneva from May 9-11, 2023.

Why is there a demand for carrageenan-free products?

There is an increasing consumer preference for vegan supplements and carrageenan-free formulations, driving manufacturers to adapt.

What markets are affected by the launch of VERDIGEL™ SC?

The launch targets the nutraceutical and dietary supplement sectors where vegan products are gaining popularity.

International Flavors & Fragrances Inc.

NYSE:IFF

IFF Rankings

IFF Latest News

IFF Stock Data

23.05B
255.53M
0.06%
93.66%
1.41%
Specialty Chemicals
Industrial Organic Chemicals
Link
United States of America
NEW YORK